Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

OrbiMed

Access Biotechnology

Bain Capital Life Sciences

Novo Holdings

Janus Henderson Investors

Rock Springs Capital

5AM Ventures

Arix Bioscience

Atlas Venture

Nantahala Capital Management

Disc Medicine

Boehringer Ingelheim Venture Fund is a venture capital firm focused on investing in early-stage biotechnology companies.

Boehringer Ingelheim Venture Fund

The Column Group LLC is a venture capital firm that invests in biotechnology companies with a focus on drug discovery and development.

The Column Group LLC

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to advancing the frontiers of biology to create life-changing medicines in the field of hematology. The company is committed to developing new therapies for a range of hematologic diseases, from rare genetic disorders to blood cancers and complications of chronic diseases.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Disc Medicine, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 9, 2024 3:37 PM	df883a4e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 9, 2024 3:37 PM	aa9b6534
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 9, 2024 3:37 PM	6e51d47a
translate crunchbase fundingrounds	general
peers	general	Feb 9, 2024 3:37 PM	df36a332
news basic	general	Feb 9, 2024 3:37 PM	c13ebea3
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:DISCMEDICINE

Disc Medicine, Inc.

Last Close

62.55

21/11 21:00

Market Cap

1.36B

Beta: -

Volume Today

358.23K

Avg: -